Nature Communications (Dec 2024)

Xenogeneic-free culture of human intestinal stem cells on functional polymer-coated substrates for scalable, clinical-grade stem cell therapy

  • Seonghyeon Park,
  • Ohman Kwon,
  • Hana Lee,
  • Younghak Cho,
  • Jemin Yeun,
  • Sung Hyun Yoon,
  • Sang Yu Sun,
  • Yubin Huh,
  • Won Dong Yu,
  • Sohee Park,
  • Naeun Son,
  • Sojeong Jeon,
  • Sugi Lee,
  • Dae-Soo Kim,
  • Sun Young Lee,
  • Jin Gyeong Son,
  • Kyung Jin Lee,
  • Yong Il Kim,
  • Jin Hong Lim,
  • Jongman Yoo,
  • Tae Geol Lee,
  • Mi-Young Son,
  • Sung Gap Im

DOI
https://doi.org/10.1038/s41467-024-54653-9
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract The need for basement membrane extract (BME) with undefined constituents, such as Matrigel, for intestinal stem cell (ISC) culture in traditional systems poses a significant barrier that must be overcome for the development of clinical-grade, scalable, ready-to-use ISCs. Here, we propose a functional polymer-based xenogeneic-free dish for the culture of intestinal stem cells (XF-DISC), ensuring substantially prolonged maintenance of ISCs derived from 3-dimensional human intestinal organoids (ISCs3D-hIO). XF-DISC enables remarkable expandability, exhibiting a 24-fold increase in cell numbers within 30 days, with long-term maintenance of ISCs3D-hIO for more than 30 consecutive passages (>210 days). In addition, XF-DISC is fully compatible with a cell banking system. Notably, human pluripotent stem cell-derived ISCs3D-hIO cultured on XF-DISC are successfully transplanted into intestinal injury and inflammation mouse models, leading to engraftment and regeneration of damaged mouse intestinal epithelium. As a reliable and scalable xenogeneic-free ISC3D-hIO culture method, XF-DISC is highly promising for the development of regenerative ISC therapy for human intestinal diseases.